Brought to you by

Scion Pharmaceuticals acquires CeNeS chemical libraries
20 Mar 2002
Executive Summary
Scion Pharmaceuticals (high-throughput electrophysiology) has acquired intellectual property related to CeNeS Pharmaceuticals' (CNS therapeutics) sodium and calcium ion channels and glutamate and sigma receptor chemical libraries.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com